| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Rosiglitazone | FAERS: 2 | US FAERS | |
| 2 | Canagliflozin | FAERS: 1 | US FAERS | |
| 3 | Ceftriaxone | FAERS: 1 | US FAERS | |
| 4 | Clopidogrel | FAERS: 1 | US FAERS | |
| 5 | Cyclosporine | FAERS: 1 | US FAERS | |
| 6 | Duloxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 7 | Finasteride | FAERS: 1 | US FAERS | |
| 8 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 9 | Naltrexone | FAERS: 1 | US FAERS | |
| 10 | Oseltamivir | FAERS: 1 | US FAERS | |
| 11 | Tetrabenazine | FAERS: 1 | US FAERS | |
| 12 | Triamcinolone Acetonide | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120242
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.